Trademarkia Logo

Canada

C$
LUNDBECK & DESIGN
REGISTERED

on 17 Mar 2021

Last Applicant/ Owned by

H. LUNDBECK A/S

Ottiliavej 92500 Valby,

DK

Serial Number

1971968 filed on 20th Jun 2019

Registration Number

TMA1095984 registered on 17th Mar 2021

Registration expiry Date

17th Mar 2031

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

LUNDBECK & DESIGN

Trademark usage description

pharmaceuticals and medical preparations and substances and vaccines for the prevention and treatment of disorders and diseases in, generated by and a Read More

Vienna Information


3 . 9 . 17

StarfishÉtoiles de mer

3 . 9 . 24

Animals of division 3.9 stylizedAnimaux de la division 3.9 stylisés

24 . 7 . 1

One flagUn drapeau

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 11

Letters underlined, overlined, framed or barred by one or more strokesLettres soulignées, surlignées, encadrées ou barrées d'un ou de plusieurs traits

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 11 . 10

Straight lines or bandsLignes ou bandes droites

26 . 4 . 2

RectanglesRectangles

26 . 4 . 9

Several quadrilaterals juxtaposed, joined or intersectingPlusieurs quadrilatères, juxtaposés, accolés ou se coupant

26 . 4 . 15

Quadrilaterals containing representations of animals or parts of animals' bodies or plantsQuadrilatères contenant la représentation d'animaux, de parties du corps d'un animal ou de végétaux

26 . 4 . 18

Quadrilaterals containing one or more lettersQuadrilatères contenant une ou plusieurs lettres

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

1 . 1 . 2

One starUne étoile

1 . 1 . 10

Stars with more than four pointsÉtoiles à plus de quatre pointes

1 . 1 . 12

Stars with uneven points -- Note: Including sparks consisting of uneven-pointed stars.Étoiles à pointes irrégulières -- Note: Y compris les étincelles constituées d'étoiles à pointes irrégulières.

1 . 1 . 1

StarsÉtoiles

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

29 . 1 . 6

White, grey, silverBlanc, gris, argent

29 . 1 . 4

BlueBleu

Classification Information


Class [005]
Pharmaceuticals and medical preparations and substances and vaccines for the prevention and treatment of disorders and diseases in, generated by and acting on the central nervous system, namely, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls due to loss of balance, movement disorders and diseases, dyskinesia, poor and absent motor functions, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and alcohol dependency; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by and acting on the central nervous system, namely dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls due to loss of balance, movement disorders and diseases, dyskinesia, poor and absent motor functions, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and alcohol dependency; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, namely dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox- Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls due to loss of balance, movement disorders and diseases, dyskinesia, poor and absent motor functions, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and alcohol dependency; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls due to loss of balance, movement disorders and diseases, dyskinesia, poor and absent motor functions, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and alcohol dependency; diagnostic reagents and agents for medical diagnostic use


Classification kind code

11

Mark Details


Serial Number

1971968

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 30th Dec 2020
Advertised
Submitted for opposition 26
on 11th Nov 2020
Approved
Submitted for opposition 27
on 11th Nov 2020
Approval Notice Sent
Submitted for opposition 12
on 4th Feb 2020
Extension of Time
Submitted for opposition 67
on 11th Sept 2019
Agent Name Changed
Submitted for opposition 22
on 19th Jul 2019
Search Recorded
Submitted for opposition 20
on 19th Jul 2019
Examiner's First Report
Submitted for opposition 31
on 27th Jun 2019
Formalized
Submitted for opposition 1
on 21st Jun 2019
Created
Submitted for opposition 30
on 20th Jun 2019
Filed